Letaplimab represents a novel medical approach for treating complement-mediated diseases. This biologic targets C1q, a essential component of the complement cascade, effectively disrupt its early activation. https://philipeiid020745.blog-gold.com/57761967/letaplimab-a-innovative-clinical-method